MARKET

ALPMY

ALPMY

Astellas Pharma
OTCPK
14.86
0.00
0.00%
Closed 15:58 09/15 EDT
OPEN
14.38
PREV CLOSE
14.86
HIGH
14.90
LOW
14.38
VOLUME
5.68K
TURNOVER
84.32K
52 WEEK HIGH
16.96
52 WEEK LOW
10.05
MARKET CAP
26.64B
P/E (TTM)
11.77
1D
5D
1M
3M
1Y
5Y
1D
Mizuho Securities Sticks to Their Hold Rating for Astellas Pharma (ALPMF)
TipRanks · 1d ago
Weekly Report: what happened at ALPMY last week (0907-0911)?
Weekly Report · 1d ago
Weekly Report: what happened at ALPMY last week (0831-0904)?
Weekly Report · 09/07 09:22
AM Markets Need to Know: Nasdaq rebounds in August, Anthropic expands AI capacity, and more
Seeking Alpha · 09/01 10:25
Trump unveils new drug-pricing accords with CSL, Astellas, and other biotech drugmakers
Seeking Alpha · 09/01 04:10
Trump Announces Drug Pricing Deals with Teva, 8 Other Companies
Barron‘s · 08/31 21:52
Trump Administration Reaches Most-Favored-Nation Drug Pricing Deals With 9 Companies
Dow Jones · 08/31 20:45
Weekly Report: what happened at ALPMY last week (0824-0828)?
Weekly Report · 08/31 09:24
More
About ALPMY
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Webull offers Astellas Pharma Inc stock information, including OTCPK: ALPMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALPMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALPMY stock methods without spending real money on the virtual paper trading platform.